Cargando…

Correction to: Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist

Detalles Bibliográficos
Autores principales:	So, Mariko, Hashimoto, Hirofumi, Saito, Reiko, Yamamoto, Yukiyo, Motojima, Yasuhito, Ueno, Hiromichi, Sonoda, Satomi, Yoshimura, Mitsuhiro, Maruyama, Takashi, Kusuhara, Koichi, Ueta, Yoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456478/ https://www.ncbi.nlm.nih.gov/pubmed/30762214 http://dx.doi.org/10.1007/s12576-019-00665-w

Ejemplares similares

Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist
por: So, Mariko, et al.
Publicado: (2017)

Activation of endogenous arginine vasopressin neurons inhibit food intake: by using a novel transgenic rat line with DREADDs system
por: Yoshimura, Mitsuhiro, et al.
Publicado: (2017)

Acute Mono-Arthritis Activates the Neurohypophysial System and Hypothalamo-Pituitary Adrenal Axis in Rats
por: Nishimura, Haruki, et al.
Publicado: (2020)

Effect of oestrogen-dependent vasopressin on HPA axis in the median eminence of female rats
por: Nishimura, Kazuaki, et al.
Publicado: (2019)

Oestrogen-dependent hypothalamic oxytocin expression with changes in feeding and body weight in female rats
por: Nishimura, Kazuaki, et al.
Publicado: (2022)

Oxytocin‐monomeric red fluorescent protein 1 synthesis in the hypothalamus under osmotic challenge and acute hypovolemia in a transgenic rat line
por: Ueno, Hiromichi, et al.
Publicado: (2020)

Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model
por: Terawaki, Kiyoshi, et al.
Publicado: (2017)

Orexin, orexin receptor antagonists and central cardiovascular control
por: Carrive, Pascal
Publicado: (2013)

Endogenous oxytocin exerts anti-nociceptive and anti-inflammatory effects in rats
por: Nishimura, Haruki, et al.
Publicado: (2022)

Hippocampus ghrelin signaling mediates appetite through lateral hypothalamic orexin pathways
por: Hsu, Ted M, et al.
Publicado: (2015)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

The effect of environmental factors in childcare facilities and individual lifestyle on obesity among Japanese preschool children; a multivariate multilevel analysis
por: Goto, Motohide, et al.
Publicado: (2019)

Expression of oxytocin in hypothalamus and reduction of nociceptive stress following administration of Kamikihi-to in female rats
por: Maruyama, Takashi, et al.
Publicado: (2022)

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
por: Yeoh, Jiann Wei, et al.
Publicado: (2014)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode
por: Shiimura, Yuki, et al.
Publicado: (2020)

Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors
por: Callander, Gabrielle E., et al.
Publicado: (2013)

Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
por: Anderson, Rachel I., et al.
Publicado: (2014)

Arginine vasopressin: Direct and indirect action on metabolism
por: Yoshimura, Mitsuhiro, et al.
Publicado: (2021)

Functional Magnetic Resonance Imaging Reveals Different Neural Substrates for the Effects of Orexin-1 and Orexin-2 Receptor Antagonists
por: Gozzi, Alessandro, et al.
Publicado: (2011)

Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
por: Fujimoto, Tatsuhiko, et al.
Publicado: (2022)

Fluorescent visualization of oxytocin in the hypothalamo-neurohypophysial system
por: Hashimoto, Hirofumi, et al.
Publicado: (2014)

The Role of Ghrelin and Ghrelin Signaling in Aging
por: Amitani, Marie, et al.
Publicado: (2017)

The clinical efficacy of orexin antagonists for primary insomnia- A review of the evidence
por: Vasiliu, O.
Publicado: (2023)

Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation
por: Beuckmann, Carsten Theodor, et al.
Publicado: (2019)

Interactions of Gastrointestinal Peptides: Ghrelin and Its Anorexigenic Antagonists
por: Wisser, Anna-Sophia, et al.
Publicado: (2010)

Osmotic perception of GABAergic synaptic transmission in the supraoptic nucleus of rats
por: Ohbuchi, Toyoaki, et al.
Publicado: (2020)

Single Gene Deletions of Orexin, Leptin, Neuropeptide Y, and Ghrelin Do Not Appreciably Alter Food Anticipatory Activity in Mice
por: Gunapala, Keith M., et al.
Publicado: (2011)

Plasma orexin-A and ghrelin levels in patients with chronic obstructive pulmonary disease: Interaction with nutritional status and body composition
por: AKBULUT, GAMZE, et al.
Publicado: (2014)

Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
por: Merlo Pich, Emilio, et al.
Publicado: (2014)

The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
por: Morairty, Stephen R., et al.
Publicado: (2014)

Formulation development for the orexin receptor antagonist almorexant: assessment in two clinical studies
por: Dingemanse, Jasper, et al.
Publicado: (2014)

Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment
por: Berger, Benjamin, et al.
Publicado: (2021)

Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist
por: Krause, Andreas, et al.
Publicado: (2022)

Upregulation of the hypothalamo-neurohypophysial system and activation of vasopressin neurones attenuates hyperalgesia in a neuropathic pain model rat
por: Baba, Kazuhiko, et al.
Publicado: (2022)

Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant
por: Dietrich, Hendrik, et al.
Publicado: (2010)

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman, Jessica L, et al.
Publicado: (2016)

Effects of the dual orexin receptor antagonist DORA-22 on sleep in 5XFAD mice
por: Duncan, Marilyn J., et al.
Publicado: (2019)

The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking
por: Khoo, Shaun Yon-Seng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_10s7cq33blfp5oon1rqm1p1i10